Trials / Unknown
UnknownNCT05737264
TAVR in Adults With Pure Severe Aortic Regurgitation
Safety and Effectiveness of Transcatheter Treatment of Severe Native Aortic Regurgitation With Self-Expandable Valve Implantation: a Multicenter, Observational,Cohort Study(SENSE-AR)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 76 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The study aimed to evaluate the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with severe native valve aortic insufficiency. It is a multicentre, observational cohort study. The primary endpoint consisted of a composite of all-cause death, disabling stroke, or rehospitalization for heart failure at 12 months postoperatively. According to previous research results and opinions of expert groups, the sample size was expected to be 76 cases.
Conditions
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-10-01
- Completion
- 2023-10-01
- First posted
- 2023-02-21
- Last updated
- 2023-05-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05737264. Inclusion in this directory is not an endorsement.